Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) swung to a net loss after Zakat and tax of SAR 58.8 million in the first nine months of 2022, from a profit of 64.6 million in the same period last year.
| Item | 9m 2021 | 9m 2022 | Change |
|---|---|---|---|
| Revenues | 1,092.12 | 1,056.98 | (3.2 %) |
| Gross Income | 461.21 | 429.08 | (7.0 %) |
| Operating Income | 68.42 | (37.10) | (154.2 %) |
| Net Income | 64.61 | (58.38) | (190.4 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | 0.54 | (0.49) | (190.4 %) |
The company said sales revenue declined 3.22 YoY, along with the repricing of some products by the Saudi Food and Drug Authority (SFDA). In addition, lower sales of one of the licensor products negatively impacted revenues.
The earnings were also weighed down by decreases in gross profit by 6.97% YoY and operating profit by 150% YoY, as selling, marketing, general and administrative expenses went up.
| Item | Q3 2021 | Q3 2022 | Change |
|---|---|---|---|
| Revenues | 311.36 | 357.02 | 14.7 % |
| Gross Income | 145.71 | 123.19 | (15.5 %) |
| Operating Income | 18.69 | (39.65) | (312.1 %) |
| Net Income | 7.40 | (45.05) | (709.1 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | 0.06 | (0.38) | (709.1 %) |
| Item | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Revenues | 310.62 | 357.02 | 14.9 % |
| Gross Income | 120.18 | 123.19 | 2.5 % |
| Operating Income | (45.26) | (39.65) | 12.4 % |
| Net Income | (46.65) | (45.05) | 3.4 % |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | (0.39) | (0.38) | 3.4 % |
The company turned to a net loss of SAR 45.5 million in Q3 2022, from a profit of SAR 7.4 million in Q3 2021.
On a sequential basis, net profit rose 12.2% from SAR 51.77 million in Q2 2021.
Shareholders’ equity, after minority interest, dropped to SAR 1.744 billion as of Sept. 30, 2022, from SAR 1.863 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}